Amedeo Smart

Free Medical Literature Service

 

Amedeo

Asthma
  Free Subscription

Articles published in
Respir Res
    April 2024
  1. LIU Y, Chen F, Zeng Z, Lei C, et al
    Neopterin in patients with COPD, asthma, and ACO: association with endothelial and lung functions.
    Respir Res. 2024;25:171.
    >> Share

  2. KOVACH MA, Kack U, Che KF, Brundin B, et al
    Systemic IL-26 correlates with improved asthma control in children sensitized to dog allergen.
    Respir Res. 2024;25:163.
    >> Share

  3. FUNG NH, Nguyen QA, Owczarek C, Wilson N, et al
    Early-life house dust mite aeroallergen exposure augments cigarette smoke-induced myeloid inflammation and emphysema in mice.
    Respir Res. 2024;25:161.
    >> Share

    March 2024
  4. BERGWIK J, Liu J, Padra M, Bhongir RKV, et al
    A novel quinoline with airway relaxant effects and anti-inflammatory properties.
    Respir Res. 2024;25:146.
    >> Share

  5. LU L, Wu F, Peng J, Wu X, et al
    Clinical characterization and outcomes of impulse oscillometry-defined bronchodilator response: an ECOPD cohort-based study.
    Respir Res. 2024;25:149.
    >> Share

  6. HSU YT, Wu CC, Wang CC, Sheu CC, et al
    Increased di-(2-ethylhexyl) phthalate exposure poses a differential risk for adult asthma clusters.
    Respir Res. 2024;25:139.
    >> Share

  7. MEI S, Li D, Wang A, Zhu G, et al
    The role of sialidase Neu1 in respiratory diseases.
    Respir Res. 2024;25:134.
    >> Share

  8. HONG X, Jiang M, Kho AT, Tiwari A, et al
    Circulating miRNAs associate with historical childhood asthma hospitalization in different serum vitamin D groups.
    Respir Res. 2024;25:118.
    >> Share

  9. CAI R, Gong X, Li X, Jiang Y, et al
    Dectin-1 aggravates neutrophil inflammation through caspase-11/4-mediated macrophage pyroptosis in asthma.
    Respir Res. 2024;25:119.
    >> Share

  10. LAN G, Xie M, Lan J, Huang Z, et al
    Association and mediation between educational attainment and respiratory diseases: a Mendelian randomization study.
    Respir Res. 2024;25:115.
    >> Share

    February 2024
  11. MATERA MG, Rinaldi B, Calabrese C, Belardo C, et al
    The effect of combining an inhaled corticosteroid and a long-acting muscarinic antagonist on human airway epithelial cells in vitro.
    Respir Res. 2024;25:104.
    >> Share

  12. SIROUX V, Boudier A, Lyon-Caen S, Quentin J, et al
    Intra-breath changes in respiratory mechanics are sensitive to history of respiratory illness in preschool children: the SEPAGES cohort.
    Respir Res. 2024;25:99.
    >> Share

  13. TU J, Wen J, Luo Q, Li X, et al
    Causal relationships of metabolites with allergic diseases: a trans-ethnic Mendelian randomization study.
    Respir Res. 2024;25:94.
    >> Share

  14. GAO J, Um-Bergstrom P, Pourbazargan M, Berggren-Brostrom E, et al
    Large airway T cells in adults with former bronchopulmonary dysplasia.
    Respir Res. 2024;25:86.
    >> Share

  15. LU T, Lahousse L, Wijnant S, Chen J, et al
    The AGE-RAGE axis associates with chronic pulmonary diseases and smoking in the Rotterdam study.
    Respir Res. 2024;25:85.
    >> Share

  16. WU W, Li J, Chen S, Ouyang S, et al
    The airway neuro-immune axis as a therapeutic target in allergic airway diseases.
    Respir Res. 2024;25:83.
    >> Share

  17. YU X, Li L, Cai B, Zhang W, et al
    Single-cell analysis reveals alterations in cellular composition and cell-cell communication associated with airway inflammation and remodeling in asthma.
    Respir Res. 2024;25:76.
    >> Share

  18. CHANG YP, Tsai YH, Chen YM, Huang KT, et al
    Upregulated microRNA-125b-5p in patients with asthma-COPD overlap mediates oxidative stress and late apoptosis via targeting IL6R/TRIAP1 signaling.
    Respir Res. 2024;25:64.
    >> Share

    January 2024
  19. AUDOUSSET C, Swaleh S, Olivenstein R, Vameghestahbanati M, et al
    Mucus plugs in the airways of asthmatic subjects and smoking status.
    Respir Res. 2024;25:52.
    >> Share

  20. REUTER S, Raspe J, Taube C
    Microbes little helpers and suppliers for therapeutic asthma approaches.
    Respir Res. 2024;25:29.
    >> Share

  21. LI Z, Cheng T, Guo Y, Gao R, et al
    CD147 induces asthmatic airway remodeling and activation of circulating fibrocytes in a mouse model of asthma.
    Respir Res. 2024;25:6.
    >> Share

  22. DETSIKA MG, Palamaris K, Dimopoulou I, Kotanidou A, et al
    The complement cascade in lung injury and disease.
    Respir Res. 2024;25:20.
    >> Share

  23. PENG W, Xia Q, Zhang Y, Cao D, et al
    VEGF and EGFR signaling pathways are involved in the baicalein attenuation of OVA-induced airway inflammation and airway remodeling in mice.
    Respir Res. 2024;25:10.
    >> Share

    December 2023
  24. LOPEZ K, Li H, Lipkin-Moore Z, Kay S, et al
    Deep learning prediction of hospital readmissions for asthma and COPD.
    Respir Res. 2023;24:311.
    >> Share

  25. EL-HUSSEINI ZW, Khalenkow D, Lan A, van der Molen T, et al
    An epithelial gene signature of trans-IL-6 signaling defines a subgroup of type 2-low asthma.
    Respir Res. 2023;24:308.
    >> Share

  26. AKENROYE A, Nopsopon T, Cho L, Moll M, et al
    Lower myostatin and higher MUC1 levels are associated with better response to mepolizumab and omalizumab in asthma: a protein-protein interaction analyses.
    Respir Res. 2023;24:305.
    >> Share

  27. HORVAT JC, Kim RY, Weaver N, Augood C, et al
    Characterization and inhibition of inflammasome responses in severe and non-severe asthma.
    Respir Res. 2023;24:303.
    >> Share

  28. HWANG H, Jang JH, Lee E, Park HS, et al
    Prediction of the number of asthma patients using environmental factors based on deep learning algorithms.
    Respir Res. 2023;24:302.
    >> Share

    November 2023
  29. CHEN B, Liu Z, Lu J, Li Z, et al
    Deep learning parametric response mapping from inspiratory chest CT scans: a new approach for small airway disease screening.
    Respir Res. 2023;24:299.
    >> Share

  30. GAGNON PA, Klein M, De Vos J, Biardel S, et al
    S100A alarmins and thymic stromal lymphopoietin (TSLP) regulation in severe asthma following bronchial thermoplasty.
    Respir Res. 2023;24:294.
    >> Share

  31. VAN DER SAR IG, Wijsenbeek MS, Braunstahl GJ, Loekabino JO, et al
    Differentiating interstitial lung diseases from other respiratory diseases using electronic nose technology.
    Respir Res. 2023;24:271.
    >> Share

  32. TEE JH, Vijayakumar U, Shanmugasundaram M, Lam TYW, et al
    Isthmin-1 attenuates allergic Asthma by stimulating adiponectin expression and alveolar macrophage efferocytosis in mice.
    Respir Res. 2023;24:269.
    >> Share

    October 2023
  33. HEMPEL P, Klein V, Michely A, Boll S, et al
    Amitriptyline inhibits bronchoconstriction and directly promotes dilatation of the airways.
    Respir Res. 2023;24:262.
    >> Share

  34. CHANG C, Chen G, Wu W, Chen D, et al
    Exogenous IL-25 ameliorates airway neutrophilia via suppressing macrophage M1 polarization and the expression of IL-12 and IL-23 in asthma.
    Respir Res. 2023;24:260.
    >> Share

  35. LIU L, Zhou L, Wang L, Mao Z, et al
    MUC1 attenuates neutrophilic airway inflammation in asthma by reducing NLRP3 inflammasome-mediated pyroptosis through the inhibition of the TLR4/MyD88/NF-kappaB pathway.
    Respir Res. 2023;24:255.
    >> Share

  36. YASUDA Y, Wang L, Chitano P, Seow CY, et al
    Critical roles of airway smooth muscle in mediating deep-inspiration-induced bronchodilation: a big stretch?
    Respir Res. 2023;24:250.
    >> Share

    September 2023
  37. SPECTOR C, De Sanctis CM, Panettieri RA Jr, Koziol-White CJ, et al
    Rhinovirus induces airway remodeling: what are the physiological consequences?
    Respir Res. 2023;24:238.
    >> Share

  38. PADILLA-GALO A, Moya Carmona I, Ausin P, Carazo Fernandez L, et al
    Achieving clinical outcomes with benralizumab in severe eosinophilic asthma patients in a real-world setting: orbe II study.
    Respir Res. 2023;24:235.
    >> Share

  39. SHEN K, Zhang M, Zhao R, Li Y, et al
    Eosinophil extracellular traps in asthma: implications for pathogenesis and therapy.
    Respir Res. 2023;24:231.
    >> Share

  40. KARAKIOULAKI M, Berkemeier CM, Heijnen I, Grize L, et al
    Staphylococcus aureus enterotoxin A- and B-specific IgE in chronic obstructive pulmonary disease.
    Respir Res. 2023;24:225.
    >> Share

  41. DEY S, Lu W, Haug G, Chia C, et al
    Airway inflammatory changes in the lungs of patients with asthma-COPD overlap (ACO): a bronchoscopy endobronchial biopsy study.
    Respir Res. 2023;24:221.
    >> Share

  42. LIU J, Chen Y, Chen H, Wang Y, et al
    Macrophage migration inhibitory factor exacerbates asthmatic airway remodeling via dynamin-related protein 1-mediated autophagy activation.
    Respir Res. 2023;24:216.
    >> Share

    August 2023
  43. YAO X, Chen Q, Wang X, Liu X, et al
    IL-25 induces airway remodeling in asthma by orchestrating the phenotypic changes of epithelial cell and fibrocyte.
    Respir Res. 2023;24:212.
    >> Share

  44. TAKEUCHI H, Hasan SMT, Zaman K, Takanashi S, et al
    Correction to: Impact of Haemophilus influenzae type b combination vaccination on asthma symptoms and pneumonia in 5-year-old children in rural Bangladesh: a longitudinal study and comparison with a previous cross-sectional study.
    Respir Res. 2023;24:210.
    >> Share

  45. DY ABC, Girkin J, Marrocco A, Collison A, et al
    Rhinovirus infection induces secretion of endothelin-1 from airway epithelial cells in both in vitro and in vivo models.
    Respir Res. 2023;24:205.
    >> Share

  46. BURBANK AJ, Atkinson CE, Espaillat AE, Schworer SA, et al
    Race-specific spirometry equations may overestimate asthma control in Black children and adolescents.
    Respir Res. 2023;24:203.
    >> Share

  47. KRAMER EL, Hudock KM, Davidson CR, Clancy JP, et al
    CFTR dysfunction in smooth muscle drives TGFbeta dependent airway hyperreactivity.
    Respir Res. 2023;24:198.
    >> Share

    July 2023
  48. JONES AC, Leffler J, Laing IA, Bizzintino J, et al
    LPS binding protein and activation signatures are upregulated during asthma exacerbations in children.
    Respir Res. 2023;24:184.
    >> Share

  49. STRULOVICI-BAREL Y, Kaner RJ, Crystal RG
    High apoptotic endothelial microparticle levels measured in asthma with elevated IgE and eosinophils.
    Respir Res. 2023;24:180.
    >> Share

  50. RASPE J, Schmitz MS, Barbet K, Caso GC, et al
    Therapeutic properties of Helicobacter pylori-derived vacuolating cytotoxin A in an animal model of chronic allergic airway disease.
    Respir Res. 2023;24:178.
    >> Share

    June 2023
  51. HAKANSSON KEJ, Guerrero SC, Backer V, Ulrik CS, et al
    Burden and unmet need for specialist care in poorly controlled and severe childhood asthma in a Danish nationwide cohort.
    Respir Res. 2023;24:173.
    >> Share

  52. WANG Z, Li Y, Gao Y, Fu Y, et al
    Global, regional, and national burden of asthma and its attributable risk factors from 1990 to 2019: a systematic analysis for the Global Burden of Disease Study 2019.
    Respir Res. 2023;24:169.
    >> Share

  53. WANG Z, He Y, Li Q, Zhao Y, et al
    Dysregulation of iron homeostasis in airways associated with persistent preschool wheezing.
    Respir Res. 2023;24:170.
    >> Share

  54. AHN SY, Lee J, Lee DH, Ho TL, et al
    Chronic allergic asthma induces T-cell exhaustion and impairs virus clearance in mice.
    Respir Res. 2023;24:160.
    >> Share

  55. DONOGHUE LJ, McFadden KM, Vargas D, Smith GJ, et al
    Collaborative cross strain CC011/UncJ as a novel mouse model of T2-high, severe asthma.
    Respir Res. 2023;24:153.
    >> Share

  56. ROGNONI C, Milano C, Heffler E, Bonini M, et al
    Economic impact of a more extensive use of FENO testing on the Italian population with asthma.
    Respir Res. 2023;24:147.
    >> Share

    May 2023
  57. KANJ AN, Kottom TJ, Schaefbauer KJ, Choudhury M, et al
    Dysbiosis of the intestinal fungal microbiota increases lung resident group 2 innate lymphoid cells and is associated with enhanced asthma severity in mice and humans.
    Respir Res. 2023;24:144.
    >> Share

  58. VULTAGGIO A, Aliani M, Altieri E, Bracciale P, et al
    Long-term effectiveness of benralizumab in severe eosinophilic asthma patients treated for 96-weeks: data from the ANANKE study.
    Respir Res. 2023;24:135.
    >> Share

  59. GENOFRE E, Carstens D, DeBacker W, Muchmore P, et al
    The effects of benralizumab on airway geometry and dynamics in severe eosinophilic asthma: a single-arm study design exploring a functional respiratory imaging approach.
    Respir Res. 2023;24:121.
    >> Share

  60. CHEN W, Reddel HK, FitzGerald JM, Beasley R, et al
    Can we predict who will benefit most from biologics in severe asthma? A post-hoc analysis of two phase 3 trials.
    Respir Res. 2023;24:120.
    >> Share

    April 2023
  61. TOMASZEWSKI EL, Atkinson MJ, Janson C, Karlsson N, et al
    Chronic Airways Assessment Test: psychometric properties in patients with asthma and/or COPD.
    Respir Res. 2023;24:106.
    >> Share

  62. LI J, Zheng Z, Liu Y, Zhang H, et al
    IRAK-M has effects in regulation of lung epithelial inflammation.
    Respir Res. 2023;24:103.
    >> Share

    March 2023
  63. HE LX, Yang L, Liu T, Li YN, et al
    Group 3 innate lymphoid cells secret neutrophil chemoattractants and are insensitive to glucocorticoid via aberrant GR phosphorylation.
    Respir Res. 2023;24:90.
    >> Share

  64. CHOI YJ, Han H, Lee JH, Lee J, et al
    Particulate matter(10)-induced airway inflammation and fibrosis can be regulated by chitinase-1 suppression.
    Respir Res. 2023;24:85.
    >> Share

  65. TALAEI M, Emmett PM, Granell R, Tabatabaeian H, et al
    Dietary patterns, lung function and asthma in childhood: a longitudinal study.
    Respir Res. 2023;24:82.
    >> Share

  66. HEIDARI-FOROOZAN M, Aryan A, Esfahani Z, Shahrbaf MA, et al
    National, subnational and risk attributed burden of chronic respiratory diseases in Iran from 1990 to 2019.
    Respir Res. 2023;24:74.
    >> Share

  67. HORTON DB, Neikirk AL, Yang Y, Huang C, et al
    Childhood asthma diagnoses declined during the COVID-19 pandemic in the United States.
    Respir Res. 2023;24:72.
    >> Share

  68. FAVERIO P, Ronco R, Monzio Compagnoni M, Franchi M, et al
    Effectiveness and economic impact of Dupilumab in asthma: a population-based cohort study.
    Respir Res. 2023;24:70.
    >> Share

    February 2023
  69. WANG XW, Wang T, Schaub DP, Chen C, et al
    Benchmarking omics-based prediction of asthma development in children.
    Respir Res. 2023;24:63.
    >> Share

  70. LIN X, Wang L, Lu X, Zhang Y, et al
    Targeting of G-protein coupled receptor 40 alleviates airway hyperresponsiveness through RhoA/ROCK1 signaling pathway in obese asthmatic mice.
    Respir Res. 2023;24:56.
    >> Share

  71. KWOK WC, Tam TCC, Lam DCL, Leung JKC, et al
    Worsening of asthma control after recovery from mild to moderate COVID-19 in patients from Hong Kong.
    Respir Res. 2023;24:53.
    >> Share

  72. XU X, Zheng F, Xu S, Hu M, et al
    Decreased ubiquitin modifying enzyme A20 associated with hyper-responsiveness to ovalbumin challenge following intrauterine growth restriction.
    Respir Res. 2023;24:50.
    >> Share

    January 2023
  73. SAFONOVA E, Yawn BP, Welte T, Wang C, et al
    Risk factors for herpes zoster: should people with asthma or COPD be vaccinated?
    Respir Res. 2023;24:35.
    >> Share

  74. TU X, Gomez HM, Kim RY, Brown AC, et al
    Airway and parenchyma transcriptomics in a house dust mite model of experimental asthma.
    Respir Res. 2023;24:32.
    >> Share

  75. GARCIA-GARCIA ML, Sastre B, Arroyas M, Beato M, et al
    Nasal TSLP and periostin in infants with severe bronchiolitis and risk of asthma at 4 years of age.
    Respir Res. 2023;24:26.
    >> Share

  76. SPRINGVLOET L, Triemstra M, Knottnerus B, Rolink M, et al
    Validation of the CaReQoL asthma: a patient reported outcome measure for monitoring the perceived effects of pulmonary rehabilitation in adult patients with severe refractory asthma.
    Respir Res. 2023;24:14.
    >> Share

  77. GOULD GS, Hurst JR, Trofor A, Alison JA, et al
    Recognising the importance of chronic lung disease: a consensus statement from the Global Alliance for Chronic Diseases (Lung Diseases group).
    Respir Res. 2023;24:15.
    >> Share

  78. QURAISHI E, Jibuaku C, Lisik D, Wennergren G, et al
    Comparison of clinician diagnosis of COVID-19 with real time polymerase chain reaction in an adult-representative population in Sweden.
    Respir Res. 2023;24:10.
    >> Share

  79. ZHOU Z, Liang S, Zhou Z, Liu J, et al
    TGF-beta1 promotes SCD1 expression via the PI3K-Akt-mTOR-SREBP1 signaling pathway in lung fibroblasts.
    Respir Res. 2023;24:8.
    >> Share

  80. BANDEIRA E, Jang SC, Lasser C, Johansson K, et al
    Effects of mesenchymal stem cell-derived nanovesicles in experimental allergic airway inflammation.
    Respir Res. 2023;24:3.
    >> Share

    December 2022
  81. CHENG WH, Kao SY, Chen CL, Yuliani FS, et al
    Amphiregulin induces CCN2 and fibronectin expression by TGF-beta through EGFR-dependent pathway in lung epithelial cells.
    Respir Res. 2022;23:381.
    >> Share

  82. CAY P, Singer CA, Ba MA
    Gene network analysis for identification of microRNA biomarkers for asthma.
    Respir Res. 2022;23:378.
    >> Share

  83. AMEGADZIE JE, Gamble JM, Farrell J, Gao Z, et al
    Risk of all-cause mortality or hospitalization for pneumonia associated with inhaled beta2-agonists in patients with asthma, COPD or asthma-COPD overlap.
    Respir Res. 2022;23:364.
    >> Share

  84. NOMURA N, Matsumoto H, Yokoyama A, Nishimura Y, et al
    Nationwide survey of refractory asthma with bronchiectasis by inflammatory subtypes.
    Respir Res. 2022;23:365.
    >> Share

  85. POURESLAMI I, FitzGerald JM, Tregobov N, Goldstein RS, et al
    Health literacy in asthma and chronic obstructive pulmonary disease (COPD) care: a narrative review and future directions.
    Respir Res. 2022;23:361.
    >> Share

  86. GRIBBEN KC, Wyss AB, Poole JA, Farazi PA, et al
    Correction to: CC16 polymorphisms in asthma, asthma subtypes, and asthma control in adults from the Agricultural Lung Health Study.
    Respir Res. 2022;23:350.
    >> Share

  87. DUPONT A, Couffignal C, Arias C, Salah K, et al
    Outcomes and risk factors with COVID-19 or influenza in hospitalized asthma patients.
    Respir Res. 2022;23:342.
    >> Share

  88. STUBBS MA, Clark VL, Gibson PG, Yorke J, et al
    Associations of symptoms of anxiety and depression with health-status, asthma control, dyspnoea, dysfunction breathing and obesity in people with severe asthma.
    Respir Res. 2022;23:341.
    >> Share

  89. ELLER MCN, Pierantozzi Vergani K, Saraiva-Romanholo BM, de Souza Xavier Costa N, et al
    Bronchial eosinophils, neutrophils, and CD8 + T cells influence asthma control and lung function in schoolchildren and adolescents with severe treatment-resistant asthma.
    Respir Res. 2022;23:335.
    >> Share

    November 2022
  90. MA L, Zhu M, Li G, Gai J, et al
    Preclinical development of a long-acting trivalent bispecific nanobody targeting IL-5 for the treatment of eosinophilic asthma.
    Respir Res. 2022;23:316.
    >> Share

  91. GRIBBEN KC, Wyss AB, Poole JA, Farazi PA, et al
    CC16 polymorphisms in asthma, asthma subtypes, and asthma control in adults from the Agricultural Lung Health Study.
    Respir Res. 2022;23:305.
    >> Share

    October 2022
  92. XIA M, Xu F, Ni H, Wang Q, et al
    Neutrophil activation and NETosis are the predominant drivers of airway inflammation in an OVA/CFA/LPS induced murine model.
    Respir Res. 2022;23:289.
    >> Share

  93. RAO X, Dong H, Zhang W, Sun H, et al
    MiR-493-5p inhibits Th9 cell differentiation in allergic asthma by targeting FOXO1.
    Respir Res. 2022;23:286.
    >> Share

  94. YI F, Zhan C, Liu B, Li H, et al
    Effects of treatment with montelukast alone, budesonide/formoterol alone and a combination of both in cough variant asthma.
    Respir Res. 2022;23:279.
    >> Share

    September 2022
  95. FALLAHZADEH A, Sharifnejad Tehrani Y, Sheikhy A, Ghamari SH, et al
    The burden of chronic respiratory disease and attributable risk factors in North Africa and Middle East: findings from global burden of disease study (GBD) 2019.
    Respir Res. 2022;23:268.
    >> Share

  96. XU J, Sun X, Zhu H, Cao Y, et al
    Long-term variability of impulse oscillometry and spirometry in stable COPD and asthma.
    Respir Res. 2022;23:262.
    >> Share

  97. DALEY-YATES P, Keppler B, Baines A, Bardsley G, et al
    Metabolomic changes related to airway inflammation, asthma pathogenesis and systemic activity following inhaled fluticasone furoate/vilanterol: a randomized controlled trial.
    Respir Res. 2022;23:258.
    >> Share

  98. MAGWENZI P, Rusakaniko S, Sibanda EN, Gumbo FZ, et al
    Challenges in the diagnosis of asthma in children, what are the solutions? A scoping review of 3 countries in sub Saharan Africa.
    Respir Res. 2022;23:254.
    >> Share

  99. LIU Y, Shi G
    Roles of sirtuins in asthma.
    Respir Res. 2022;23:251.
    >> Share

  100. LEUNG C, Ryu MH, Bolling AK, Maestre-Batlle D, et al
    Peroxisome proliferator-activated receptor gamma gene variants modify human airway and systemic responses to indoor dibutyl phthalate exposure.
    Respir Res. 2022;23:248.
    >> Share

  101. FENG KN, Meng P, Zou XL, Zhang M, et al
    IL-37 protects against airway remodeling by reversing bronchial epithelial-mesenchymal transition via IL-24 signaling pathway in chronic asthma.
    Respir Res. 2022;23:244.
    >> Share

  102. ZHOU J, Yi F, Wu F, Xu P, et al
    Characteristics of different asthma phenotypes associated with cough: a prospective, multicenter survey in China.
    Respir Res. 2022;23:243.
    >> Share

  103. LEE HW, Baek MG, Choi S, Ahn YH, et al
    Peripheral blood transcriptomic clusters uncovered immune phenotypes of asthma.
    Respir Res. 2022;23:237.
    >> Share

  104. ALTHOFF MD, Jimenez G, Peterson R, Jin Y, et al
    Differences in L-arginine metabolism and asthma morbidity among asthma patients with and without obstructive sleep apnea.
    Respir Res. 2022;23:230.
    >> Share

    August 2022
  105. ROGLIANI P, Cavalli F, Ritondo BL, Cazzola M, et al
    Sex differences in adult asthma and COPD therapy: a systematic review.
    Respir Res. 2022;23:222.
    >> Share

    July 2022
  106. BODUM KS, Hjerrild BE, Dalsgaard S, Rubak SLM, et al
    Behavioural side effects of inhaled corticosteroids among children and adolescents with asthma.
    Respir Res. 2022;23:192.
    >> Share

  107. KAN M, Sun M, Jiang X, Diwadkar AR, et al
    CEBPD modulates the airway smooth muscle transcriptomic response to glucocorticoids.
    Respir Res. 2022;23:193.
    >> Share

  108. RIEG AD, Suleiman S, Anker C, Bunting NA, et al
    Platelet-derived growth factor (PDGF)-BB regulates the airway tone via activation of MAP2K, thromboxane, actin polymerisation and Ca(2+)-sensitisation.
    Respir Res. 2022;23:189.
    >> Share

  109. CHEN CH, Wu CD, Lee YL, Lee KY, et al
    Air pollution enhance the progression of restrictive lung function impairment and diffusion capacity reduction: an elderly cohort study.
    Respir Res. 2022;23:186.
    >> Share

  110. BIGNOLD R, Shammout B, Rowley JE, Repici M, et al
    Chemokine CXCL12 drives pericyte accumulation and airway remodeling in allergic airway disease.
    Respir Res. 2022;23:183.
    >> Share

    June 2022
  111. GOUDARZI H, Kimura H, Kimura H, Makita H, et al
    Effects of obesity on CC16 and their potential role in overweight/obese asthma.
    Respir Res. 2022;23:174.
    >> Share

  112. LE NPK, do Nascimento AF, Schneberger D, Quach CC, et al
    Deficiency of leukocyte-specific protein 1 (LSP1) alleviates asthmatic inflammation in a mouse model.
    Respir Res. 2022;23:165.
    >> Share

    May 2022
  113. IHRIE MD, McQuade VL, Womble JT, Hegde A, et al
    Exogenous leptin enhances markers of airway fibrosis in a mouse model of chronic allergic airways disease.
    Respir Res. 2022;23:131.
    >> Share

  114. JACKSON D, Walum J, Banerjee P, Lewis BW, et al
    Th1 cytokines synergize to change gene expression and promote corticosteroid insensitivity in pediatric airway smooth muscle.
    Respir Res. 2022;23:126.
    >> Share

  115. HUANG K, Li F, Wang X, Yan B, et al
    Clinical and cytokine patterns of uncontrolled asthma with and without comorbid chronic rhinosinusitis: a cross-sectional study.
    Respir Res. 2022;23:119.
    >> Share

  116. LIU Y, Qu HQ, Qu J, Chang X, et al
    Burden of rare coding variants reveals genetic heterogeneity between obese and non-obese asthma patients in the African American population.
    Respir Res. 2022;23:116.
    >> Share

    April 2022
  117. LI R, Chen Y, Zhao A, Huang L, et al
    Exploring genetic association of insomnia with allergic disease and asthma: a bidirectional Mendelian randomization study.
    Respir Res. 2022;23:84.
    >> Share

    March 2022
  118. YU C, Huang W, Zhou Z, Liang S, et al
    Short isoform thymic stromal lymphopoietin reduces inflammation and aerobic glycolysis of asthmatic airway epithelium by antagonizing long isoform thymic stromal lymphopoietin.
    Respir Res. 2022;23:75.
    >> Share

  119. HOFFMANN C, Maglakelidze M, von Schneidemesser E, Witt C, et al
    Asthma and COPD exacerbation in relation to outdoor air pollution in the metropolitan area of Berlin, Germany.
    Respir Res. 2022;23:64.
    >> Share

  120. WEITOFT M, Kadefors M, Stenberg H, Tufvesson E, et al
    Plasma proteome changes linked to late phase response after inhaled allergen challenge in asthmatics.
    Respir Res. 2022;23:50.
    >> Share

  121. KORN S, Howarth P, Smith SG, Price RG, et al
    Development of methodology for assessing steroid-tapering in clinical trials for biologics in asthma.
    Respir Res. 2022;23:45.
    >> Share

    February 2022
  122. CHEN Y, Kong D, Fu J, Zhang Y, et al
    Associations between ambient temperature and adult asthma hospitalizations in Beijing, China: a time-stratified case-crossover study.
    Respir Res. 2022;23:38.
    >> Share

  123. MENZELLA F, Bargagli E, Aliani M, Bracciale P, et al
    ChAracterization of ItaliaN severe uncontrolled Asthmatic patieNts Key features when receiving Benralizumab in a real-life setting: the observational rEtrospective ANANKE study.
    Respir Res. 2022;23:36.
    >> Share

  124. SCHAUNAMAN N, Dimasuay KG, Kraft M, Chu HW, et al
    Tollip interaction with STAT3: a novel mechanism to regulate human airway epithelial responses to type 2 cytokines.
    Respir Res. 2022;23:31.
    >> Share

    January 2022
  125. WU W, Gao J, Chen D, Chen G, et al
    Epithelial microRNA-30a-3p targets RUNX2/HMGB1 axis to suppress airway eosinophilic inflammation in asthma.
    Respir Res. 2022;23:17.
    >> Share

    December 2021
  126. SKIBBA ME, Xu X, Weiss K, Huisken J, et al
    Role of Secretoglobin(+) (club cell) NFkappaB/RelA-TGFbeta signaling in aero-allergen-induced epithelial plasticity and subepithelial myofibroblast transdifferentiation.
    Respir Res. 2021;22:315.
    >> Share

  127. MASPERO J, Agache IO, Kamei T, Yoshida M, et al
    Long-term safety and exploratory efficacy of fevipiprant in patients with inadequately controlled asthma: the SPIRIT randomised clinical trial.
    Respir Res. 2021;22:311.
    >> Share

  128. BURBANK AJ, Schworer SA, Sood A, Almond M, et al
    Airway IL-1beta associates with IL-5 production following dust mite allergen inhalation in humans.
    Respir Res. 2021;22:309.
    >> Share

    November 2021
  129. KOSHY K, Sha J, Bennetts K, Langton D, et al
    Safety of delivering bronchial thermoplasty in two treatment sessions.
    Respir Res. 2021;22:307.
    >> Share

  130. SVERRILD A, Leadbetter J, Porsbjerg C
    The use of the mannitol test as an outcome measure in asthma intervention studies: a review and practical recommendations.
    Respir Res. 2021;22:287.
    >> Share

    October 2021
  131. HARDING JN, Gross M, Patel V, Potter S, et al
    Association between particulate matter containing EPFRs and neutrophilic asthma through AhR and Th17.
    Respir Res. 2021;22:275.
    >> Share

  132. TUPPER OD, Ulrik CS
    Long-term predictors of severe exacerbations and mortality in a cohort of well-characterised adults with asthma.
    Respir Res. 2021;22:269.
    >> Share

  133. CARSTENSEN S, Gress C, Erpenbeck VJ, Kazani SD, et al
    Prostaglandin D2 metabolites activate asthmatic patient-derived type 2 innate lymphoid cells and eosinophils via the DP2 receptor.
    Respir Res. 2021;22:262.
    >> Share

    August 2021
  134. ZHANG S, Fan Y, Qin L, Fang X, et al
    IL-1beta augments TGF-beta inducing epithelial-mesenchymal transition of epithelial cells and associates with poor pulmonary function improvement in neutrophilic asthmatics.
    Respir Res. 2021;22:216.
    >> Share

    April 2021
  135. HEALY C, Munoz-Wolf N, Strydom J, Faherty L, et al
    Nutritional immunity: the impact of metals on lung immune cells and the airway microbiome during chronic respiratory disease.
    Respir Res. 2021;22:133.
    >> Share

    February 2021
  136. LI LY, Yan TS, Yang J, Li YQ, et al
    Impulse oscillometry for detection of small airway dysfunction in subjects with chronic respiratory symptoms and preserved pulmonary function.
    Respir Res. 2021;22:68.
    >> Share

  137. SAITO T, Ichikawa T, Numakura T, Yamada M, et al
    PGC-1alpha regulates airway epithelial barrier dysfunction induced by house dust mite.
    Respir Res. 2021;22:63.
    >> Share

  138. VAN DEN BERG MPM, Nijboer-Brinksma S, Bos IST, van den Berge M, et al
    The novel TRPA1 antagonist BI01305834 inhibits ovalbumin-induced bronchoconstriction in guinea pigs.
    Respir Res. 2021;22:48.
    >> Share

  139. WANG Y, Liao K, Liu B, Niu C, et al
    GITRL on dendritic cells aggravates house dust mite-induced airway inflammation and airway hyperresponsiveness by modulating CD4(+) T cell differentiation.
    Respir Res. 2021;22:46.
    >> Share


Free Medical Abstracts
Privacy Policy
Sponsors
Share

© Amedeo 1997-2016